REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLEK.L Regulatory News (LEK)

  • There is currently no data for LEK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

16 May 2022 07:00

RNS Number : 5278L
Lekoil Limited
16 May 2022
 

16 May 2022

Lekoil Limited

("LEKOIL" or the "Company")

Notice of application for admission to the Aquis Stock Exchange and Cancellation of Admission to trading on AIM

LEKOIL (AIM: LEK), announces that it has applied for admission of its Ordinary Shares to trading on the Access segment of the AQSE Growth Market operated by the Aquis Stock Exchange (AQSE). It is expected that admission will occur on 18 May 2022 and that trading will commence on AQSE as soon as the audited accounts for the Company are released to the market, expected to be by the end of June 2022.

 

The Company's Ordinary Shares have been suspended from trading on AIM since October 2021. Pursuant to AIM Rule 41, admission of the Company's shares to trading on AIM will be cancelled with effect from 7.00 a.m. on 18 May 2022 with the Company's shares being admitted to trading on the AQSE Growth Market from this time.

Moving from AIM to AQSE will not affect a shareholder's legal or beneficial right to his or her shares. Shareholders are not required to take any action at this stage.

 

Anthony Hawkins, Interim Executive Chairman, commented:

"The Board of the Company considers AQSE to be a suitable exchange to provide for the continued listing of its shares.

The Board is of the view that the Company's primary activity is now the recovery of its investment through litigation against the Lekoil Nigeria group and Mr. Akinyanmi. This characterisation will allow the Company to fulfil its disclosure obligations to the AQSE market, noting that a successful recovery of the intercompany debts due to the Company will be the primary source of value for shareholders (with minimal value attributable to the day-to-day operational activities of Lekoil Nigeria).

With respect to the suspension of the Company's shares from trading on AQSE, the Company has a clear understanding as to what is required to restore trading in the Company's shares on AQSE and we are diligently working through that plan. We will update our shareholders on this matter as soon as is practicable.

In selecting the AQSE Growth Market, the Board was keen to provide shareholders with the services of a regulated SME Growth market and a trading facility while it pursues its litigation assets, and its strategy unfolds."

 

With effect from the cancellation of the admission of the Company's shares to trading on AIM SP Angel Corporate Finance LLP will cease to act as Nominated Adviser and joint broker to the Company.

 

The Company's shares will continue to be registered with the existing ISIN number KYG5462G1073 and SEDOL number B9FFQF9. The Company's ticker symbol will continue to be LEK.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

For further information, please visit www.lekoilplc.com or contact:

Lekoil Limited

Anthony Hawkins

 

info@lekoilplc.com

SP Angel Corporate Finance LLP (AIM Nominated Adviser and Joint Broker)

Jeff Keating / Stuart Gledhill

 

+44 20 3470 0470

First Sentinel Corporate Finance Limited (AQSE Corporate Adviser)

Brian Stockbridge

 

+44 20 3989 2200

Tennyson Securities (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 20 7186 9030

Camarco (Financial PR Advisor)

Billy Clegg / Owen Roberts / Violet Wilson

+44 20 3757 4983

  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDAAMLTMTIBMAT
Date   Source Headline
22nd Dec 202012:24 pmRNSRE Extraordinary General Meeting
18th Dec 20207:15 amRNSRe Otakikpo Marginal Field
18th Dec 20207:00 amRNSExtension of Director Loan
17th Dec 202012:58 pmRNSRE Extraordinary General Meeting
11th Dec 20208:00 amRNSPosting of Circular and Notice of EGM
11th Dec 20207:00 amRNSPayments to Optimum Petroleum Development Company
23rd Nov 20206:03 pmRNSRequisition of Extraordinary General Meeting
23rd Nov 20207:30 amRNSSuspension - Lekoil Limited
23rd Nov 20207:15 amRNSNominated Adviser Update
19th Nov 20202:45 pmRNSHolding(s) in Company
16th Nov 20204:41 pmRNSSecond Price Monitoring Extn
16th Nov 20204:36 pmRNSPrice Monitoring Extension
16th Nov 20202:05 pmRNSSecond Price Monitoring Extn
16th Nov 20202:00 pmRNSPrice Monitoring Extension
16th Nov 202011:05 amRNSSecond Price Monitoring Extn
16th Nov 202011:00 amRNSPrice Monitoring Extension
16th Nov 20207:00 amRNSResignation of Nominated Adviser
11th Nov 20207:00 amRNSRepayment of Prepayment Facility
30th Oct 20207:00 amRNSInterim Results 2020
29th Oct 20207:00 amRNSStrategic Alliance Agreement with NAMCOR
28th Sep 20207:00 amRNSInterims Reporting Timeline and Optimum Payment
25th Sep 20204:46 pmRNSResult of AGM and Board Changes
2nd Sep 20207:00 amRNSAnnual Report and Notice of Annual General Meeting
1st Sep 202011:54 amRNSTR-1: notification of major holdings
26th Aug 20207:05 amRNSHolding(s) in Company
26th Aug 20207:00 amRNSFinal Results
25th Aug 20207:00 amRNSJoint Broker Appointment
17th Aug 20207:00 amRNSRestructuring of Existing Term Loans
23rd Jul 202012:08 pmRNSSecond Price Monitoring Extn
23rd Jul 202012:02 pmRNSPrice Monitoring Extension
15th Jul 20205:10 pmRNSConfirmation of completed Optimum Payment
15th Jul 20204:00 pmRNSJoint Broker Resignation
13th Jul 20207:00 amRNSAgreements for Otakikpo Drilling Executed
10th Jul 20207:00 amRNSHolding(s) in Company
3rd Jul 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jul 20204:36 pmRNSPrice Monitoring Extension
2nd Jul 20207:00 amRNSPrepayment Facility
26th Jun 20207:00 amRNSExtension of annual results and trading update
17th Jun 202012:08 pmRNSSecond Price Monitoring Extn
17th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 20204:41 pmRNSSecond Price Monitoring Extn
15th Jun 20204:36 pmRNSPrice Monitoring Extension
8th Jun 20207:00 amRNSTR-1: notification of major holdings
29th May 20204:41 pmRNSSecond Price Monitoring Extn
29th May 20204:36 pmRNSPrice Monitoring Extension
30th Apr 20207:00 amRNSRe-structure of Financial Obligations to Optimum
24th Apr 202012:08 pmRNSSecond Price Monitoring Extn
24th Apr 202012:02 pmRNSPrice Monitoring Extension
21st Apr 20207:00 amRNSDirectorate Changes
20th Apr 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.